257 related articles for article (PubMed ID: 21725368)
21. A Synthetic Cell-Penetrating Dominant-Negative ATF5 Peptide Exerts Anticancer Activity against a Broad Spectrum of Treatment-Resistant Cancers.
Karpel-Massler G; Horst BA; Shu C; Chau L; Tsujiuchi T; Bruce JN; Canoll P; Greene LA; Angelastro JM; Siegelin MD
Clin Cancer Res; 2016 Sep; 22(18):4698-711. PubMed ID: 27126996
[TBL] [Abstract][Full Text] [Related]
22. miRNA-21 is developmentally regulated in mouse brain and is co-expressed with SOX2 in glioma.
Põlajeva J; Swartling FJ; Jiang Y; Singh U; Pietras K; Uhrbom L; Westermark B; Roswall P
BMC Cancer; 2012 Aug; 12():378. PubMed ID: 22931209
[TBL] [Abstract][Full Text] [Related]
23. Targeting ATF5 in Cancer.
Angelastro JM
Trends Cancer; 2017 Jul; 3(7):471-474. PubMed ID: 28718401
[TBL] [Abstract][Full Text] [Related]
24. Retroviral delivery of platelet-derived growth factor to spinal cord progenitor cells drives the formation of intramedullary gliomas.
Ellis JA; Castelli M; Bruce JN; Canoll P; Ogden AT
Neurosurgery; 2012 Jan; 70(1):198-204; discussion 204. PubMed ID: 21760556
[TBL] [Abstract][Full Text] [Related]
25. Glioma tumor grade correlates with parkin depletion in mutant p53-linked tumors and results from loss of function of p53 transcriptional activity.
Viotti J; Duplan E; Caillava C; Condat J; Goiran T; Giordano C; Marie Y; Idbaih A; Delattre JY; Honnorat J; Checler F; Alves da Costa C
Oncogene; 2014 Apr; 33(14):1764-75. PubMed ID: 23644658
[TBL] [Abstract][Full Text] [Related]
26. Cell of origin determines tumor phenotype in an oncogenic Ras/p53 knockout transgenic model of high-grade glioma.
Ghazi SO; Stark M; Zhao Z; Mobley BC; Munden A; Hover L; Abel TW
J Neuropathol Exp Neurol; 2012 Aug; 71(8):729-40. PubMed ID: 22805776
[TBL] [Abstract][Full Text] [Related]
27. BCL-2 is a downstream target of ATF5 that mediates the prosurvival function of ATF5 in a cell type-dependent manner.
Dluzen D; Li G; Tacelosky D; Moreau M; Liu DX
J Biol Chem; 2011 Mar; 286(9):7705-13. PubMed ID: 21212266
[TBL] [Abstract][Full Text] [Related]
28. PDGF Engages an E2F-USP1 Signaling Pathway to Support ID2-Mediated Survival of Proneural Glioma Cells.
Rahme GJ; Zhang Z; Young AL; Cheng C; Bivona EJ; Fiering SN; Hitoshi Y; Israel MA
Cancer Res; 2016 May; 76(10):2964-76. PubMed ID: 26951930
[TBL] [Abstract][Full Text] [Related]
29. DNA methylation level of promoter region of activating transcription factor 5 in glioma.
Hua XM; Wang J; Qian DM; Song JY; Chen H; Zhu XL; Zhou R; Zhao YD; Zhou XZ; Li L; Zhang L; Song XX; Wang B
J Zhejiang Univ Sci B; 2015 Sep; 16(9):757-62. PubMed ID: 26365117
[TBL] [Abstract][Full Text] [Related]
30. Signal transducer and activator of transcription 5b drives malignant progression in a PDGFB-dependent proneural glioma model by suppressing apoptosis.
Gressot LV; Doucette TA; Yang Y; Fuller GN; Heimberger AB; Bögler O; Rao A; Latha K; Rao G
Int J Cancer; 2015 May; 136(9):2047-54. PubMed ID: 25302990
[TBL] [Abstract][Full Text] [Related]
31. Early induction of angiogenetic signals in gliomas of GFAP-v-src transgenic mice.
Theurillat JP; Hainfellner J; Maddalena A; Weissenberger J; Aguzzi A
Am J Pathol; 1999 Feb; 154(2):581-90. PubMed ID: 10027415
[TBL] [Abstract][Full Text] [Related]
32. Tumor-specific activation of the C-JUN/MELK pathway regulates glioma stem cell growth in a p53-dependent manner.
Gu C; Banasavadi-Siddegowda YK; Joshi K; Nakamura Y; Kurt H; Gupta S; Nakano I
Stem Cells; 2013 May; 31(5):870-81. PubMed ID: 23339114
[TBL] [Abstract][Full Text] [Related]
33. Role of Btg2 in the progression of a PDGF-induced oligodendroglioma model.
Appolloni I; Curreli S; Caviglia S; Barilari M; Gambini E; Pagano A; Malatesta P
Int J Mol Sci; 2012 Nov; 13(11):14667-78. PubMed ID: 23203087
[TBL] [Abstract][Full Text] [Related]
34. Cardioprotection by the mitochondrial unfolded protein response requires ATF5.
Wang YT; Lim Y; McCall MN; Huang KT; Haynes CM; Nehrke K; Brookes PS
Am J Physiol Heart Circ Physiol; 2019 Aug; 317(2):H472-H478. PubMed ID: 31274354
[TBL] [Abstract][Full Text] [Related]
35. Macrophage migration inhibitory factor (MIF) expression in human malignant gliomas contributes to immune escape and tumour progression.
Mittelbronn M; Platten M; Zeiner P; Dombrowski Y; Frank B; Zachskorn C; Harter PN; Weller M; Wischhusen J
Acta Neuropathol; 2011 Sep; 122(3):353-65. PubMed ID: 21773885
[TBL] [Abstract][Full Text] [Related]
36. The neuroprotective transcription factor ATF5 is decreased and sequestered into polyglutamine inclusions in Huntington's disease.
Hernández IH; Torres-Peraza J; Santos-Galindo M; Ramos-Morón E; Fernández-Fernández MR; Pérez-Álvarez MJ; Miranda-Vizuete A; Lucas JJ
Acta Neuropathol; 2017 Dec; 134(6):839-850. PubMed ID: 28861715
[TBL] [Abstract][Full Text] [Related]
37. Characterization of Tu-2449, a glioma cell line derived from a spontaneous tumor in GFAP-v-src-transgenic mice: comparison with established murine glioma cell lines.
Pohl U; Wick W; Weissenberger J; Steinbach JP; Dichgans J; Aguzzi A; Weller M
Int J Oncol; 1999 Oct; 15(4):829-34. PubMed ID: 10493969
[TBL] [Abstract][Full Text] [Related]
38. [The distribution of glial fibrillary acidic protein and protein S-100 in experimental brain tumors in rats].
Khalanskiĭ AS; Shevchenko GM; Berezin VA
Zh Vopr Neirokhir Im N N Burdenko; 1991; (1):19-22. PubMed ID: 1649519
[TBL] [Abstract][Full Text] [Related]
39. Fasting induced up-regulation of activating transcription factor 5 in mouse liver.
Shimizu YI; Morita M; Ohmi A; Aoyagi S; Ebihara H; Tonaki D; Horino Y; Iijima M; Hirose H; Takahashi S; Takahashi Y
Life Sci; 2009 Jun; 84(25-26):894-902. PubMed ID: 19376136
[TBL] [Abstract][Full Text] [Related]
40. The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.
Solga AC; Toonen JA; Pan Y; Cimino PJ; Ma Y; Castillon GA; Gianino SM; Ellisman MH; Lee DY; Gutmann DH
Oncotarget; 2017 Jul; 8(29):47206-47215. PubMed ID: 28525381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
